4AB:FRA
AbbVie Common Stock
âĴ220.80
arrow_downward
-1.65%(-3.70) 1D
Sep 4, 10:00:00âŻPM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
âĴ222.70
High
âĴ222.70
Low
âĴ220.80
Mkt. cap
453.19B
Avg. vol.
64.00
Volume
65.00
52-wk high
âĴ234.40
52-wk low
âĴ167.55
No. of employees
57K
Open
âĴ222.70
High
âĴ222.70
Low
âĴ220.80
Mkt. cap
453.19B
Avg. vol.
64.00
Volume
65.00
52-wk high
âĴ234.40
52-wk low
âĴ167.55
No. of employees
57K
News stories
From web sources and news partners
TechStock²
·
13 hours ago
AbbVie Closes $10.9 Billion Apogee Deal; Earnings Payoff Starts in 2032
The Globe and Mail
·
15 hours ago
Scotiabank Remains a Buy on AbbVie (ABBV)
MarketWatch
·
1 day ago
AbbVie Inc. stock underperforms Friday when compared to competitors
The Motley Fool
·
1 day ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com